The role of SH groups in opiate-receptor interactions has been further examined. Inactivation by N-ethylmaleimide of stereospecific opiate binding by rat brain membrane fractions follows pseudo-first order kinetics and exhibits strong temperature dependence. The kinetics indicate that alkylation of a single SH group suffices to block opiate binding. Considerable protection from SH group inactivation is observed when treatment with N-ethylmaleimide is carried out in the presence of an opiate or an antagonist, suggesting close proximity of the SH group to the opiate binding site. The rate of inactivation of receptor binding by N-ethylmaleimide is markedly slower in buffers containing 100 mM NaCl (ti/2 = 30 4-1.4 min) than in sodium-free buffers (t'/2 = 10 + 1.0 min).
Since the rate of alkylation of model SH compounds is unaffected by sodium ions, this protection seems best explained by a conformational change in the receptors that renders the SH groups less accessible to alkylation. The rate of inactivation is not affected by K+, Rb+, or Cs+ and only slightly by Li+. This cation specificity as well as the concentration-response to Na+ are remarkably similar to those previously shown to lead to increased antagonist and decreased agonist binding. We suggest that the same conformational change is involved in the two phenomena.
The existence of stereospecific binding sites for opiates and opiate antagonists in the brain of animals was discovered independently in three laboratories, including our own (1-3), by a modification of an assay first suggested by Goldstein et al. (4) . Confirmation in many laboratories followed and much evidence has accumulated suggesting that these sites represent pharmacological receptors. Opiate receptors have also been observed in human brain obtained at autopsy (5) .
Because we noted (3) that addition of salt decreases binding of the potent agonist etorphine, and Pert and Snyder (2) found no effect of salt on the binding of the antagonist naloxone, we suggested that the differential effect of salt may reflect a general difference in the manner in which agonists and antagonists bind to the receptor (3). This generalization was confirmed by the studies of Pert et al. (6) , who further showed that discrimination between agonists and antagonists was a specific property of sodium salts, the binding of antagonists being stimulated in the presence of sodium ions. Our recent studies on the mechanism of the sodium effect (7) suggest that sodium acts as an allosteric effector causing a conformational change in the receptor molecule. The resulting "sodium-dependent" form has a higher affinity for antagonists and a lower affinity for agonists than the "sodium-free" form, but the total number of receptor sites does not change. Residual stereospecific binding of [3H naltrexone was then assayed. In kinetic studies the concentration of protecting drug used was 3 nM.
Protein was estimated by the method of Lowry et al. (10) . A P2 membrane fraction derived from a 1:60 homogenate had 0.9-1.2 mg of protein per ml. RESULTS Kinetics of Inactivation and Proteetion by Opiates. When rat brain P2 membranes are incubated with NEM and the reaction is stopped by destruction of excess NEM, there is a progressive decrease in their capacity to bind [3HJnaltrexonie stereospecifically. As shown in Fig. 1 , the rate of inactivation follows pseudo-first order kinetics, as would be expected at high NEM concentration (NEM concentration essentially constant) if reaction occurs with a single SH group on the receptor. It also exhibits a strong dependence on temperature, the half-time of inactivation being increased from 9 min to 35 min when the temperature is decreased from 370 to 260.
Inactivation at 00 is exceedingly slow. When the binding of the potent narcotic analgesic [3H]etorphine is assayed, both the rate and extent of inactivation by NEM are the same as for naltrexone. Similar first-order kinetics have also been obtained for inactivation of binding by p-hydroxymercuribenzoate and iodoacetamide.
When preincubation with NEM is performed in the presence of an opiate or opiate antagonist there is considerable protection. Fig. 2 shows the rate of inactivation by NEM in the presence and absence of 3 nM naltrexone. The half-time of inactivation is increased from 9 to 25 min. Similar protection has been observed with levorphanol. Larger concentrations of drug can be used if they are subsequently removed by careful washing before binding assays are performed, although protection was generally not complete even with levels of opiate up to 0.1 or 1 uAM.
Specific Protection from NEMlI Inactivation by Sodium Ions.
When preincubation of P2 membranes with NEM is carried out in 100 mM NaCI, the rate of inactivation is markedly decreased (Fig. 3) Fig. 4 shows the protective effects of various concentrations of sodium. Protection increases with concentrations of NaCl from essentially none at 1 mM to maximal protection at 100 mM, remaining the same or declining slightly at 200 mM NaCl. This concentration-response is identical to that which we previously reported for enhancement of antagonist binding at different NaCl concentrations (7) .
Protection by sodium has also been observed when stereospecific binding is assayed with the potent agonist [3H1-etorphine. Inactivation by iodoacetamide is similarly retarded by the presence of sodium salts.
Saturation experiments with and without Na+ were carried out with P2 membranes in which binding capacity had been reduced 80% by treatment with NEM. The residual binding sites were found to be identical to those in untreated membranes with respect to the affinity of naltrexone in the absence (KD = 1.1 nM) and presence (KD = 0.5 nM) of NaCl, indicating that the uninhibited binding sites retain their original properties.
Incorporation of [3H]NEAI. To determine whether or not NaCl produces a change in the rate of alkylation of all or most of the SH groups present in P2 membranes of rat brain, we studied the rate of incorporation of [3H]NEM into the membranes (Fig. 5) . The rates and extents of incorporation are identical in KC1 and NaCl. The plateau of incorporation The present results also provide independent evidence for a conformational transformation of receptors when membranes are transferred from a sodium-free to a sodium-containing buffer (or vice versa). This model was previously suggested by us (7, 12) on the basis of the sodium-induced alteration in opposite directions of binding affinities of agonists and antagonists. Since the rate of reaction between NEM and mdoel SH compounds is unaffected by the presence of NaCl, the marked slowing down in the rate of receptor inactivation by NEM is most simply explained by a conformational change in the receptor caused by NaCi, which renders a vital SH group less accessible to inactivation. The hypothesis that a conformational change occurs and that it may be the same as that previously postulated for changes in binding affinities is supported by the finding that the protection from inactivation by NEM exhibits the same cation specificity and concentrationresponse relationship to NaCl as is observed for enhancement of antagonist binding.
The observation that the rate of incorporation of [3H]NEM into P2 membranes is identical in KC1 and NaCl provides evidence that the change that occurs in the presence of sodium does not affect all or most of the SH groups present in the membranes. Since there are, however, approximately 105 SH groups for every one that is involved in opiate binding, it is clearly not possible to conclude that sodium affects only receptor SH groups. One can conclude that decreased accessibility is exhibited by only a fraction of total membrane SH groups, and it is attractive to speculate that the change may occur only in proteins whose structures are appropriately altered by bound sodium ions.
Evidence accumulated to date is consistent with competition of opiate agonists and antagonists for the same binding site. This hypothesis is strengthened by the present results which show protection from inactivation of SH groups by both agonists and antagonists. Moreover, protection of receptor sites by sodium ions is observed regardless of whether an antagonist (naltrexone) or an agonist (etorphine) is used in the binding assay.
